Right ventricular failure secondary to chronic overload in congenital heart diseases: Benefits of cell therapy using human embryonic stem cell-derived cardiac progenitors

Journal of Thoracic and Cardiovascular Surgery

Volumn 149, Issue 3, 2015, Pages 708-715.e1

  Lambert, Virginie ^a,b   Gouadon, Elodie ^a,b   Capderou, André ^a,b   Le Bret, Emmanuel ^a   Ly, Mohamed ^a   Dinanian, Sylvie ^c   Renaud, Jean Francois ^a,b   Pucéat, Miche ^d   Rücker Martin, Catherine ^a,b  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c Centre Hospitalier Antoine Béclère   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

STAGE SPECIFIC EMBRYO ANTIGEN 1; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CARDIAC STEM CELL; CELL THERAPY; CENTRAL VENOUS PRESSURE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; EMBRYONIC STEM CELL; ENERGY TRANSFER; FALLOT TETRALOGY; FIBROSING ALVEOLITIS; HEART EJECTION FRACTION; HEART INDEX; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE ENDSYSTOLIC VOLUME; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE OVERLOAD; HEMODYNAMICS; HISTOLOGY; HOLTER MONITORING; HUMAN; HUMAN CELL; MALE; MESODERMAL CELL; MUSCLE CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QRS COMPLEX; ST SEGMENT DEPRESSION; WEIGHT GAIN; ADVERSE EFFECTS; ANIMAL; ARRHYTHMIAS, CARDIAC; CARDIAC MUSCLE CELL; CELL LINE; COMPLICATION; CONVALESCENCE; DISEASE MODEL; EVALUATION STUDY; FEASIBILITY STUDY; FIBROSIS; HEART CONTRACTION; HEART RIGHT VENTRICLE FUNCTION; HEART SURGERY; HEART VENTRICLE REMODELING; INTRAMUSCULAR DRUG ADMINISTRATION; METABOLISM; PATHOPHYSIOLOGY; PIG; REGENERATION; TETRALOGY OF FALLOT; TIME FACTOR; TRANSPLANTATION;

ANIMALS; ARRHYTHMIAS, CARDIAC; BIOMARKERS; CARDIAC SURGICAL PROCEDURES; CELL LINE; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; FEASIBILITY STUDIES; FIBROSIS; HEMODYNAMICS; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; RECOVERY OF FUNCTION; REGENERATION; SWINE; TETRALOGY OF FALLOT; TIME FACTORS; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR REMODELING;

EID: 84926147982     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2014.11.033     Document Type: Article

References (33)

1. K. Norozi, A. Wessel, V. Alpers, J.O. Arnhold, S. Geyer, and M. Zoege Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery Am J Cardiol 97 2006 1238 1243
2. L. Lopez, M.S. Cohen, R.H. Anderson, A.N. Redington, D.G. Nykanen, and D.J. Penny Unnatural history of the right ventricle in patients with congenitally malformed hearts Cardiol Young 20 Suppl 3 2010 107 112
3. A. Vonk-Noordegraaf, F. Haddad, K.M. Chin, P.R. Forfia, S.M. Kawut, and J. Lumens Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology J Am Coll Cardiol 62 25 Suppl 2013 D22 D33
4. N.F. Voelkel, R.A. Quaife, L.A. Leinwand, R.J. Barst, M.D. McGoon, and D.R. Meldrum Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure Circulation 114 2006 1883 1891
5. M.M. Winter, B.J. Bouma, M. Groenink, T.C. Konings, J.G. Tijssen, and D.J. van Veldhuisen Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure Heart 95 2009 960 963
6. J.J. Chong, X. Yang, C.W. Don, E. Minami, Y.W. Liu, and J.J. Weyers Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts Nature 510 2014 273 277
7. N. Borenstein, Z. Jian, G. Fromont, P. Bruneval, M. Hekmati, and L. Behr Noncultured cell transplantation in an ovine model of right ventricular preparation J Thorac Cardiovasc Surg 129 2005 1119 1127
8. C. Yerebakan, E. Sandica, S. Prietz, C. Klopsch, M. Ugurlucan, and A. Kaminski Autologous umbilical cord blood mononuclear cell transplantation preserves right ventricular function in a novel model of chronic right ventricular volume overload Cell Transplant 18 2009 855 868
9. B. Davies, N.J. Elwood, S. Li, F. Cullinane, G.A. Edwards, and D.F. Newgreen Human cord blood stem cells enhance neonatal right ventricular function in an ovine model of right ventricular training Ann Thorac Surg 89 2010 585 593 e581-4
10. V. Lambert, A. Capderou, E. Le Bret, C. Rucker-Martin, E. Deroubaix, and E. Gouadon Right ventricular failure secondary to chronic overload in congenital heart disease: an experimental model for therapeutic innovation J Thorac Cardiovasc Surg 139 2010 1197 1204 e1191
11. M.F. Kozak, A. Redington, S.J. Yoo, M. Seed, A. Greiser, and L. Grosse-Wortmann Diffuse myocardial fibrosis following tetralogy of Fallot repair: a t1 mapping cardiac magnetic resonance study Pediatr Radiol 44 2014 403 409
12. R. Bolli, X.L. Tang, S.K. Sanganalmath, O. Rimoldi, F. Mosna, and A. Abdel-Latif Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy Circulation 128 2013 122 131
13. G. Blin, D. Nury, S. Stefanovic, T. Neri, O. Guillevic, and B. Brinon A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates J Clin Invest 120 2010 1125 1139
14. A.L.X. Richart, and T. Neri Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome Circulation 113 2006 405 413
15. H. Takaoka, M. Takeuchi, M. Odake, and M. Yokoyama Assessment of myocardial oxygen consumption (vo2) and systolic pressure-volume area (pva) in human hearts Eur Heart J 13 Suppl E 1992 85 90
16. S. Francois, M. Mouiseddine, N. Mathieu, A. Semont, P. Monti, and N. Dudoignon Human mesenchymal stem cells favour healing of the cutaneous radiation syndrome in a xenogenic transplant model Ann Hematol 86 2007 1 8
17. F. Haddad, R. Doyle, D.J. Murphy, and S.A. Hunt Right ventricular function in cardiovascular disease, part ii: pathophysiology, clinical importance, and management of right ventricular failure Circulation 117 2008 1717 1731
18. U.K. Chowdhury, S. Sathia, R. Ray, R. Singh, K.K. Pradeep, and P. Venugopal Histopathology of the right ventricular outflow tract and its relationship to clinical outcomes and arrhythmias in patients with tetralogy of Fallot J Thorac Cardiovasc Surg 132 2006 270 277
19. T. Geva Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2006 11 22
20. P. Menasche Stem cell therapy for heart failure: Are arrhythmias a real safety concern' Circulation 119 2009 2735 2740
21. M.A. Laflamme, and C.E. Murry Regenerating the heart Nature Biotechnol 23 2005 845 856
22. M.A. Gatzoulis, J.A. Till, J. Somerville, and A.N. Redington Mechanoelectrical interaction in tetralogy of fallot. Qrs prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death Circulation 92 1995 231 237
23. C. Rucker-Martin, P. Milliez, S. Tan, X. Decrouy, M. Recouvreur, and R. Vranckx Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts Cardiovasc Res 72 2006 69 79
24. P. Milliez, S. Gomes, L. Champ-Rigot, J. Callebert, J.L. Samuel, and C. Delcayre Effects of spironolactone alone and in addition to a beta-blocker on myocardial histological and electrical remodeling in chronic severe failing rat hearts J Cardiovasc Pharmacol 60 2012 315 321
25. C. Mias, O. Lairez, E. Trouche, J. Roncalli, D. Calise, and M.H. Seguelas Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction Stem Cells 27 2009 2734 2743
26. E. Puymirat, R. Geha, A. Tomescot, V. Bellamy, J. Larghero, and L. Trinquart Can mesenchymal stem cells induce tolerance to cotransplanted human embryonic stem cells' Mol Ther 17 2009 176 182
27. A.L.X. Richart, T. Néri, K. Howangyin, C. Guérin, A. Ngkelo, and W. Bakker Microrna-21 coordinates human multipotent cardiovascular progenitors: therapeutic potential and post-ischemic revascularization Stem Cells 32 2014 2908 2922
28. P.R. Crisostomo, A.M. Abarbanell, M. Wang, T. Lahm, Y. Wang, and D.R. Meldrum Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions Am J Physiol Heart Circ Physiol 295 2008 H1726 H1735
29. D. Calderon, V. Planat-Benard, V. Bellamy, V. Vanneaux, C. Kuhn, and S. Peyrard Immune response to human embryonic stem cell-derived cardiac progenitors and adipose-derived stromal cells J Cell Mol Med 16 2012 1544 1552
30. T.A. Marino, R.L. Kent, C.E. Uboh, E. Fernandez, E.W. Thompson, and G.T. Cooper Structural analysis of pressure versus volume overload hypertrophy of cat right ventricle Am J Physiol 249 2 Pt 2 1985 H371 H379
31. K.C. Wollert, and H. Drexler Clinical applications of stem cells for the heart Circ Res 96 2005 151 163
32. M. de Vroomen, R.H. Cardozo, P. Steendijk, F. van Bel, and J. Baan Improved contractile performance of right ventricle in response to increased rv afterload in newborn lamb Am J Physiol Heart Circ Physiol 278 2000 H100 H105
33. M.A. Laflamme, K.Y. Chen, A.V. Naumova, V. Muskheli, J.A. Fugate, and S.K. Dupras Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts Nat Biotechnol 25 2007 1015 1024